Global Gene Therapy Market Report 2024

Gene Therapy Global Market Report 2023 – By Gene Type (Antigen, Cytokine, Suicide Gene, Other Gene types), By Vector (Viral Vector, Non-Viral Vector, Other Vectors), By Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Other Applications), By End Users (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 250 | Published : January 2023 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Gene Therapy Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Gene therapy refers to a method for treating or curing sickness that alters a person's DNA. Gene treatments can function in a variety of ways: putting a healthy copy of the gene in place of a disease-causing gene, and putting a defective gene that causes an illness inactive.

The main types of gene therapy are antigens, cytokines, suicide genes, and others. The antigen is a poison or other foreign substance that triggers an immunological response in the body, including antibody formation. The different vectors include viral vectors, non-viral vectors, and others and are used in oncological disorders, rare diseases, cardiovascular diseases, neurological disorders, infectious diseases, and others. it is implemented in various sectors, such as hospitals, homecare, specialty clinics, and others.

The global gene therapy market is segmented -

1) By Gene Type: Antigen, Cytokine, Suicide Gene, and Other Gene Types

2) By Vector: Viral Vector, Non-Viral Vector, Other Vectors

3) By Application: Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Other Applications

4) By End Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

The global gene therapy market grew from $7.37 billion in 2022 to $9.42 billion in 2023 at a compound annual growth rate (CAGR) of 27.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of gene therapy is expected to grow from $24.03 billion in 2027 at a CAGR of 26.4%.

Incidences of cancer and other target diseases have been increasing significantly, which is calling for effective treatments, driving the growth of the gene therapy market. The rise in the number of cancer cases across the globe is likely to contribute to the growth of the gene therapy market during the forecast period. For instance, in January 2022, according to the American Cancer Society, there will likely be 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the US, or roughly 1,670 fatalities every day. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43 percent of all new cancer cases. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43 percent of all new cancer cases. Therefore, the rise in the cancer incidence rate globally is anticipated to boost the demand for the gene therapy market over the forthcoming years. Gene therapy is one of the most effective treatments in oncology. In this treatment, new genes are introduced into a cancerous cell or the surrounding tissue to cause cell death or slow the growth of cancer.

Major players in the gene therapy market are Novartis AG, Bluebird Bio Inc., Spark Therapeutics Inc., Audentes Therapeutics, Voyager Therapeutics, Applied Genetic Technologies Corporation, UniQure N.V., Celgene Corporation, Cellectis S.A., and Sangamo Therapeutics.

The high prices of gene therapy medicines are expected to limit the growth of the gene therapy market. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective therapies for cancer and other diseases has influenced the health conditions of the population and led to a low average life expectancy. Luxturna, a one-time treatment for acquired retinal eye disease, costs $850,000 in the US and £613,410 in the UK, despite a markdown that is applied through Britain's National Health Service. Zolgensma, for spinal muscular atrophy, is valued at $2.1 million in the US, while Zynteglo, which focuses on a rare genetic blood disorder, costs $1.78 million, thus restraining the growth of the market.

The use of machine learning and artificial intelligence is gradually gaining popularity in the gene therapy market. Artificial intelligence (AI) is the simulation of human intelligence in machines, which are programmed to display their natural intelligence. Machine learning is a part of AI. Machine learning and AI help companies in the gene therapy market conduct a detailed analysis of all relevant data, provide insights between tumour and immune cell interactions, and offer a more accurate evaluation of tissue samples, which is often disputed between different evaluators. For instance, since January 2020, GlaxoSmithKline, a pharmaceutical company, has been investing in AI to optimise gene therapy and develop off-the-shelf solutions for patients. It is also expected to reduce turnaround time and the cost of gene therapies.

In December 2021, Novartis AG, a Switzerland-based pharmaceutical company specialising in the discovery, development, manufacturing, and commercialization of medicines, acquired Gyroscope Therapeutics Holdings plc for an amount of $800 million. Through this acquisition, GT005, an experimental, one-time gene therapy now in Phase 2 for the treatment of persons with geographic atrophy (GA), will be added to the Novartis portfolio, increasing gene therapy research capabilities and bringing ophthalmic innovation to treat and prevent blindness globally. Gyroscope Therapeutics Holdings plc is a UK-based clinical stage biopharmaceutical company pioneering in the research and development of gene therapies for the treatment of eye related diseases.

North America was the largest region in the gene therapy market in 2022. The regions covered in the gene therapy market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the gene therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The gene therapy market includes revenues earned by entities by replacing a disease-causing gene with a healthy copy of the gene and inactivating a disease-causing gene that is not functioning properly. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products.

The gene therapy market research report is one of a series of new reports from The Business Research Company that provides gene therapy market statistics, including gene therapy industry global market size, regional shares, competitors with a gene therapy market share, detailed gene therapy market segments, market trends and opportunities, and any further data you may need to thrive in the gene therapy industry. This gene therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

    Table Of Contents

    1. Executive Summary

    2. Table Of Contents

    3. List Of Figures

    4. List Of Tables

    5. Report Structure

    6. Introduction And Market Characteristics

    6.1. General Market Definition

    6.2. Summary

    6.3. Gene Therapy Market Definition And Segmentations

    6.4. Market Segmentation By Gene Therapy Type

    6.4.1. Germline Therapy

    6.4.2. Somatic Cell Therapy

    6.5. Market Segmentation By Vector

    6.5.1. Viral Vector

    6.5.2. Non-Viral Vector

    6.6. Market Segmentation By End Users

    6.6.1. Biopharmaceutical Companies

    6.6.2. Research Institutes

    6.6.3. Other End Users

    6.7. Market Segmentation By Application

    6.7.1. Oncology

    6.7.2. Orphan Disease

    6.7.3. Knee Osteoarthritis

    6.7.4. Neurological Disorders

    7. Major Market Trends

    7.1. Growing Investments and Manufacturing Facility Expansion

    7.2. Use Of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology

    7.3. Launch Of Cell And Gene Therapy Platforms

    7.4. Partnerships And Collaborations

    7.5. Rising Focus On Gene Editing

    7.6. Strategic Mergers And Acquisitions

    8. Global Market Size and Growth

    8.1. Market Size

    8.2. Historic Market Growth, 2017 – 2022, Value ($ Million)

    8.2.1. Market Drivers 2017 – 2022

    8.2.2. Market Restraints 2017 – 2022

    8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    8.3.1. Market Drivers 2022 – 2027

    8.3.2. Market Restraints 2022 – 2027

    9. Global Gene Therapy Market Segmentation

    9.1. Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    9.2. Global Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    9.3. Global Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    9.4. Global Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    10. Gene Therapy Market, Regional and Country Analysis

    10.1. Global Gene Therapy Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    10.2. Global Gene Therapy Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11. Asia-Pacific Market

    11.1. Summary

    11.2. Market Overview

    11.2.1. Region Information

    11.2.2. Market Information

    11.2.3. Background Information

    11.2.4. Government Initiatives

    11.2.5. Regulations

    11.2.6. Regulatory Bodies

    11.2.7. Major Associations

    11.2.8. Taxes Levied

    11.2.9. Corporate Tax Structure

    11.2.10. Investments

    11.2.11. Major Companies

    11.3. Asia-Pacific Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    11.4. Asia-Pacific Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    11.5. Asia-Pacific Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.6. Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.7. Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.8. Asia-Pacific Gene Therapy Market: Country Analysis

    11.9. China Market

    11.10. Summary

    11.11. Market Overview

    11.11.1. Country Information

    11.11.2. Market Information

    11.11.3. Background Information

    11.11.4. Government Initiatives

    11.11.5. Regulations

    11.11.6. Regulatory Bodies

    11.11.7. Major Associations

    11.11.8. Taxes Levied

    11.11.9. Corporate Tax Structure

    11.11.10. Investments

    11.11.11. Major Companies

    11.12. China Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    11.13. China Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    11.14. China Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.15. China Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.16. China Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.17. India Market

    11.18. India Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    11.19. India Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    11.20. India Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.21. India Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.22. India Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.23. Japan Market

    11.24. Japan Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    11.25. Japan Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    11.26. Japan Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.27. Japan Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.28. Japan Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.29. Australia Market

    11.30. Australia Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    11.31. Australia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    11.32. Australia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.33. Australia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.34. Australia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.35. Indonesia Market

    11.36. Indonesia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    11.37. Indonesia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.38. Indonesia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.39. Indonesia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.40. South Korea Market

    11.41. South Korea Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    11.42. South Korea Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    11.43. South Korea Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.44. South Korea Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    11.45. South Korea Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    12. Western Europe Market

    12.1. Summary

    12.2. Market Overview

    12.2.1. Region Information

    12.2.2. Market Information

    12.2.3. Background Information

    12.2.4. Government Initiatives

    12.2.5. Regulations

    12.2.6. Regulatory Bodies

    12.2.7. Major Associations

    12.2.8. Taxes Levied

    12.2.9. Corporate Tax Structure

    12.2.10. Investments

    12.2.11. Major Companies

    12.3. Western Europe Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    12.4. Western Europe Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    12.5. Western Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    12.6. Western Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    12.7. Western Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    12.8. Western Europe Gene Therapy Market: Country Analysis

    12.9. UK Market

    12.10. UK Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    12.11. UK Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    12.12. UK Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    12.13. UK Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    12.14. UK Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    12.15. Germany Market

    12.16. Germany Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    12.17. Germany Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    12.18. Germany Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    12.19. Germany Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    12.20. Germany Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    12.21. France Market

    12.22. France Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    12.23. France Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    12.24. France Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    12.25. France Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    12.26. France Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    13. Eastern Europe Market

    13.1. Summary

    13.2. Market Overview

    13.2.1. Region Information

    13.2.2. Market Information

    13.2.3. Background Information

    13.2.4. Government Initiatives

    13.2.5. Regulations

    13.2.6. Regulatory Bodies

    13.2.7. Major Associations

    13.2.8. Taxes Levied

    13.2.9. Corporate Tax Structure

    13.2.10. Investments

    13.2.11. Major Companies

    13.3. Eastern Europe Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    13.4. Eastern Europe Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    13.5. Eastern Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    13.6. Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    13.7. Eastern Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    13.8. Eastern Europe Gene Therapy Market: Country Analysis

    13.9. Russia Market

    13.10. Russia Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    13.11. Russia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    13.12. Russia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    13.13. Russia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    13.14. Russia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    14. North America Market

    14.1. Summary

    14.2. Market Overview

    14.2.1. Region Information

    14.2.2. Market Information

    14.2.3. Background Information

    14.2.4. Government Initiatives

    14.2.5. Regulations

    14.2.6. Regulatory Bodies

    14.2.7. Major Associations

    14.2.8. Taxes Levied

    14.2.9. Corporate Tax Structure

    14.2.10. Investments

    14.2.11. Major Companies

    14.3. North America Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    14.4. North America Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    14.5. North America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    14.6. North America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    14.7. North America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    14.8. North America Gene Therapy Market: Country Analysis

    14.9. USA Market

    14.10. Summary

    14.11. Market Overview

    14.11.1. Country Information

    14.11.2. Market Information

    14.11.3. Background Information

    14.11.4. Government Initiatives

    14.11.5. Regulations

    14.11.6. Regulatory Bodies

    14.11.7. Major Associations

    14.11.8. Taxes Levied

    14.11.9. Corporate Tax Structure

    14.11.10. Investments

    14.11.11. Major Companies

    14.12. USA Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    14.13. USA Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    14.14. USA Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    14.15. USA Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    14.16. USA Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    15. South America Market

    15.1. Summary

    15.2. Market Overview

    15.2.1. Region Information

    15.2.2. Market Information

    15.2.3. Background Information

    15.2.4. Government Initiatives

    15.2.5. Regulations

    15.2.6. Regulatory Bodies

    15.2.7. Major Associations

    15.2.8. Taxes Levied

    15.2.9. Corporate Tax Structure

    15.2.10. Investments

    15.2.11. Major Companies

    15.3. South America Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    15.4. South America Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    15.5. South America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    15.6. South America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    15.7. South America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    15.8. South America Gene Therapy Market: Country Analysis

    15.9. Brazil Market

    15.10. Brazil Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    15.11. Brazil Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    15.12. Brazil Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    15.13. Brazil Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    15.14. Brazil Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    16. Middle East Market

    16.1. Summary

    16.2. Market Overview

    16.2.1. Region Information

    16.2.2. Market Information

    16.2.3. Background Information

    16.2.4. Government Initiatives

    16.2.5. Regulations

    16.2.6. Regulatory Bodies

    16.2.7. Major Associations

    16.2.8. Taxes Levied

    16.2.9. Corporate Tax Structure

    16.2.10. Investments

    16.2.11. Major Companies

    16.3. Middle East Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    16.4. Middle East Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    16.5. Middle East Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    16.6. Middle East Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    16.7. Middle East Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    17. Africa Market

    17.1. Summary

    17.2. Market Overview

    17.2.1. Region Information

    17.2.2. Market Information

    17.2.3. Background Information

    17.2.4. Government Initiatives

    17.2.5. Regulations

    17.2.6. Regulatory Bodies

    17.2.7. Major Associations

    17.2.8. Taxes Levied

    17.2.9. Corporate Tax Structure

    17.2.10. Investments

    17.2.11. Major Companies

    17.3. Africa Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

    17.4. Africa Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

    17.5. Africa Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    17.6. Africa Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    17.7. Africa Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

    18. Competitive Landscape and Company Profiles

    18.1. Company Profiles

    18.2. Novartis AG

    18.2.1. Company Overview

    18.2.2. Products And Services

    18.2.3. Business Strategy

    18.2.4. Financial Overview

    18.3. F. Hoffmann-La Roche AG

    18.3.1. Company Overview

    18.3.2. Products And Services

    18.3.3. Business Strategy

    18.3.4. Financial Overview

    18.4. Gilead Sciences Inc.

    18.4.1. Company Overview

    18.4.2. Products And Services

    18.4.3. Financial Overview

    18.5. Astellas Pharma Inc.

    18.5.1. Company Overview

    18.5.2. Products And Services

    18.5.3. Business Strategy

    18.5.4. Financial Overview

    18.6. Biogen Inc.

    18.6.1. Company Overview

    18.6.2. Products And Services

    18.6.3. Business Strategy

    18.6.4. Financial Overview

    19. Key Mergers And Acquisitions

    19.1. Rocket Pharmaceuticals Acquired Renovacor

    19.2. Eli Lilly Acquired Akouos

    19.3. Ginkgo Bioworks Acquired Altar and Circularis

    19.4. Solvias Acquired Cergentis

    19.5. Novartis Acquired Gyroscope Therapeutics

    19.6. FHI Clinical Acquired Triclinium Clinical Development

    19.7. WuXi AppTec Acquired OXGENE

    20. Pipeline Analysis

    20.1. Products In Development

    20.2. Approved Products

    21. Opportunities And Strategies

    21.1. Global Gene Therapy Market In 2027 – Countries Offering Most New Opportunities

    21.2. Global Gene Therapy Market In 2027 – Segments Offering Most New Opportunities

    21.3. Global Gene Therapy Market In 2027 – Growth Strategies

    21.3.1. Market Trend Based Strategies

    21.3.2. Competitor Strategies

    22. Gene Therapy Market, Conclusions And Recommendations

    22.1. Conclusions

    22.2. Recommendations

    22.2.1. Product

    22.2.2. Place

    22.2.3. Price

    22.2.4. Promotion

    22.2.5. People

    23. Appendix

    23.1. Market Data Sources

    23.2. Research Methodology

    23.3. Currencies

    23.4. The Business Research Company

    23.5. Copyright and Disclaimer

List Of Tables

    Table 1: Global Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 2: Global Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 3: Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 4: Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 5: Global Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 6: Global Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 7: Global Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 8: Global Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 9: Global Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 10: Global Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 11: Global Gene Therapy Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 12: Global Gene Therapy Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 13: Global Gene Therapy Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 14: Global Gene Therapy Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 15: Asia-Pacific GDP Per Capita, By Country, 2017-2022, $
  • Table 16:  Asia-Pacific Population, By Country, 2017-2027, Millions
  • Table 17: Asia-Pacific, Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
  • Table 18: Asia-Pacific Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 19: Asia-Pacific Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 20: Asia-Pacific Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 21: Asia-Pacific Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 22: Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 23: Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 24: Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 25: Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 26: China GDP Per Capita, 2017-2022, $
  • Table 27:  China Population, 2017-2027, Millions
  • Table 28: China Pharmaceuticals Market Size, 2017-2027, $ Billion
  • Table 29: China Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 30: China Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 31: China Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 32: China Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 33: China Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 34: China Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 35: China Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 36: China Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 37: India Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 38: India Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 39: India Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 40: India Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 41: India Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 42: India Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 43: India Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 44: India Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 45: Japan Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 46: Japan Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 47: Japan Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 48: Japan Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 49: Japan Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 50: Japan Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 51: Japan Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 52: Japan Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 53: Australia Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 54: Australia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 55: Australia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 56: Australia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 57: Australia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 58: Australia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 59: Australia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 60: Australia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 61: Indonesia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 62: Indonesia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 63: Indonesia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 64: Indonesia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 65: Indonesia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 66: Indonesia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 67: Indonesia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 68: South Korea Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 69: South Korea Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 70: South Korea Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 71: South Korea Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 72: South Korea Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 73: South Korea Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 74: South Korea Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 75: South Korea Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 76: Western Europe GDP Per Capita, By Country, 2017-2022, $
  • Table 77:  Western Europe Population, By Country, 2017-2027, Millions
  • Table 78: Western Europe Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
  • Table 79: Western Europe Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 80: Western Europe Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 81: Western Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 82: Western Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 83: Western Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 84: Western Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 85: Western Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 86: Western Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 87: UK Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 88: UK Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 89: UK Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 90: UK Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 91: UK Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 92: UK Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 93: UK Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 94: UK Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 95: Germany Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 96: Germany Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 97: Germany Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 98: Germany Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 99: Germany Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 100: Germany Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 101: Germany Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 102: Germany Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 103: France Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 104: France Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 105: France Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 106: France Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 107: France Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 108: France Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 109: France Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 110: France Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 111: Eastern Europe GDP Per Capita, By Country, 2017-2022, $
  • Table 112:  Eastern Europe Population, By Country, 2017-2027, Millions
  • Table 113: Eastern Europe Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
  • Table 114: Eastern Europe Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 115: Eastern Europe Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 116: Eastern Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 117: Eastern Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 118: Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 119: Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 120: Eastern Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 121: Eastern Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 122: Russia Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 123: Russia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 124: Russia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 125: Russia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 126: Russia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 127: Russia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 128: Russia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 129: Russia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 130: North America GDP Per Capita, By Country, 2017-2022, $
  • Table 131:  North America Population, By Country, 2017-2027, Millions
  • Table 132: North America Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
  • Table 133: North America Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 134: North America Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 135: North America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 136: North America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 137: North America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 138: North America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 139: North America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 140: North America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 141: USA GDP Per Capita, 2017-2022, $
  • Table 142:  USA Population, 2017-2027, Millions
  • Table 143: USA Pharmaceuticals Market Size, 2017-2027, $ Billion
  • Table 144: USA Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 145: USA Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 146: USA Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 147: USA Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 148: USA Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 149: USA Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 150: USA Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 151: USA Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 152: South America GDP Per Capita, By Country, 2017-2022, $
  • Table 153:  South America Population, By Country, 2017-2027, Millions
  • Table 154: South America Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
  • Table 155: South America Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 156: South America Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 157: South America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 158: South America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 159: South America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 160: South America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 161: South America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 162: South America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 163: Brazil Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 164: Brazil Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 165: Brazil Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 166: Brazil Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 167: Brazil Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 168: Brazil Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 169: Brazil Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 170: Brazil Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 171: Middle East GDP Per Capita, By Country, 2017-2022, $
  • Table 172:  Middle East Population, By Country, 2017-2027, Millions
  • Table 173: Middle East Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
  • Table 174: Middle East Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 175: Middle East Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 176: Middle East Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 177: Middle East Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 178: Middle East Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 179: Middle East Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 180: Middle East Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 181: Middle East Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 182: Africa GDP Per Capita, By Country, 2017-2022, $
  • Table 183:  Africa Population, By Country, 2017-2027, Millions
  • Table 184: Africa Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
  • Table 185: Africa Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Table 186: Africa Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Table 187: Africa Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 188: Africa Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 189: Africa Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 190: Africa Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 191: Africa Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Table 192: Africa Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
  • Table 193: Global Gene Therapy Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
  • Table 194:  Novartis – Financial Performance, 2017– 2021, $Billion
  • Table 195: Roche – Financial Performance, 2017– 2021, $Billion
  • Table 196: Gilead – Financial Performance, 2017– 2021, $Billion
  • Table 197: Astellas – Financial Performance, 2017– 2021, $Billion
  • Table 198: Biogen – Financial Performance, 2017– 2021, $Billion
  • Table 199: Global Gene Therapy Market, Pipeline Analysis
  • Table 200: Global Gene Therapy Market, Approved Products
  • Table 201: Global Gene Therapy Market Type Gain ($ Million), 2022 – 2027, By Country
  • Table 202: Global Gene Therapy Market Type Gain ($ Million), Segmentation By Gene Therapy Type, 2022 – 2027
  • Table 203: Global Gene Therapy Market Type Gain ($ Million), Segmentation By Vector, 2022 – 2027
  • Table 204: Global Gene Therapy Market Type Gain ($ Million), Segmentation By End Users, 2022 – 2027
  • Table 205: Global Gene Therapy Market Type Gain ($ Million), Segmentation By Application, 2022 – 2027
  • Table 206: Gene Therapy - Market Data Sources

List Of Figures

    Figure 1: Geographic Regions Covered
  • Figure 2: Global Gene Therapy Market Segmentation By Gene Therapy Type
  • Figure 3: Global Gene Therapy Market Segmentation By Vector
  • Figure 4: Global Gene Therapy Market Segmentation By End Users
  • Figure 5: Global Gene Therapy Market Segmentation By Application
  • Figure 6: Global Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 7: Global Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 8: Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 9: Global Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 10: Global Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 11: Global Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 12: Global Gene Therapy Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 13: Global Gene Therapy Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 14: Asia-Pacific Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 15: Asia-Pacific Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 16: Asia-Pacific Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 17: Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 18: Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 19: China Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 20: China Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 21: China Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 22: China Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 23: China Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 24: India Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 25: India Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 26: India Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 27: India Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 28: India Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 29: Japan Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 30: Japan Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 31: Japan Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 32: Japan Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 33: Japan Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 34: Australia Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 35: Australia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 36: Australia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 37: Australia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 38: Australia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 39: Indonesia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 40: Indonesia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 41: Indonesia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 42: Indonesia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 43: South Korea Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 44: South Korea Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 45: South Korea Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 46: South Korea Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 47: South Korea Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 48: Western Europe Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 49: Western Europe Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 50: Western Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 51: Western Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 52: Western Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 53: UK Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 54: UK Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 55: UK Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 56: UK Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 57: UK Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 58: Germany Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 59: Germany Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 60: Germany Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 61: Germany Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 62: Germany Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 63: France Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 64: France Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 65: France Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 66: France Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 67: France Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 68: Eastern Europe Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 69: Eastern Europe Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 70: Eastern Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 71: Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 72: Eastern Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 73: Russia Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 74: Russia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 75: Russia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 76: Russia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 77: Russia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 78: North America Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 79: North America Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 80: North America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 81: North America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 82: North America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 83: USA Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 84: USA Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 85: USA Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 86: USA Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 87: USA Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 88: South America Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 89: South America Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 90: South America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 91: South America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 92: South America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 93: Brazil Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 94: Brazil Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 95: Brazil Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 96: Brazil Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 97: Brazil Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 98: Middle East Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 99: Middle East Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 100: Middle East Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 101: Middle East Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 102: Middle East Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 103: Africa Gene Therapy Market, Historic, 2017 – 2022, $ Million
  • Figure 104: Africa Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million
  • Figure 105: Africa Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 106: Africa Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 107: Africa Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
  • Figure 108: Global Gene Therapy Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
  • Figure 109: Novartis – Financial Performance, 2017– 2021, $Billion
  • Figure 110: Roche – Financial Performance, 2017– 2021, $Billion
  • Figure 111: Gilead – Financial Performance, 2017– 2021, $Billion
  • Figure 112: Astellas – Financial Performance, 2017– 2021, $Billion
  • Figure 113: Biogen – Financial Performance, $Billion
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report